NIOCORP DEVELOPMENTS LTD (NB) Fundamental Analysis & Valuation

NASDAQ:NB • CA6544846091

Current stock price

5.58 USD
-0.07 (-1.24%)
At close:
5.58 USD
0 (0%)
Pre-Market:

This NB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NB Profitability Analysis

1.1 Basic Checks

  • NB had negative earnings in the past year.
  • In the past year NB has reported a negative cash flow from operations.
  • NB had negative earnings in each of the past 5 years.
  • In the past 5 years NB always reported negative operating cash flow.
NB Yearly Net Income VS EBIT VS OCF VS FCFNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of NB (-16.71%) is worse than 74.23% of its industry peers.
  • NB has a worse Return On Equity (-18.84%) than 68.71% of its industry peers.
Industry RankSector Rank
ROA -16.71%
ROE -18.84%
ROIC N/A
ROA(3y)-96.06%
ROA(5y)-71.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NB Yearly ROA, ROE, ROICNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • NB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NB Yearly Profit, Operating, Gross MarginsNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. NB Health Analysis

2.1 Basic Checks

  • NB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NB has more shares outstanding
  • There is no outstanding debt for NB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NB Yearly Shares OutstandingNB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NB Yearly Total Debt VS Total AssetsNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • NB has an Altman-Z score of 12.01. This indicates that NB is financially healthy and has little risk of bankruptcy at the moment.
  • NB has a better Altman-Z score (12.01) than 78.53% of its industry peers.
  • There is no outstanding debt for NB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.01
ROIC/WACCN/A
WACCN/A
NB Yearly LT Debt VS Equity VS FCFNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 31.45 indicates that NB has no problem at all paying its short term obligations.
  • NB has a better Current ratio (31.45) than 96.32% of its industry peers.
  • A Quick Ratio of 31.45 indicates that NB has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 31.45, NB belongs to the top of the industry, outperforming 96.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 31.45
Quick Ratio 31.45
NB Yearly Current Assets VS Current LiabilitesNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. NB Growth Analysis

3.1 Past

  • The earnings per share for NB have decreased strongly by -328.10% in the last year.
EPS 1Y (TTM)-328.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 25.16% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-103.57%
EPS Next 2Y7.74%
EPS Next 3Y-12.62%
EPS Next 5Y25.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NB Yearly Revenue VS EstimatesNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
NB Yearly EPS VS EstimatesNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. NB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NB. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NB Price Earnings VS Forward Price EarningsNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NB Per share dataNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A cheap valuation may be justified as NB's earnings are expected to decrease with -12.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.74%
EPS Next 3Y-12.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NB Dividend Analysis

5.1 Amount

  • NB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NB Fundamentals: All Metrics, Ratios and Statistics

NIOCORP DEVELOPMENTS LTD

NASDAQ:NB (4/29/2026, 8:00:01 PM)

Premarket: 5.58 0 (0%)

5.58

-0.07 (-1.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Industry Strength89.44
Industry Growth27.33
Earnings (Last)02-06
Earnings (Next)05-06
Inst Owners26.2%
Inst Owner Change0.19%
Ins Owners2.12%
Ins Owner Change3.61%
Market Cap796.43M
Revenue(TTM)N/A
Net Income(TTM)-58.17M
Analysts85
Price Target11.88 (112.9%)
Short Float %6.93%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.18%
Min EPS beat(2)2.91%
Max EPS beat(2)51.46%
EPS beat(4)3
Avg EPS beat(4)12.19%
Min EPS beat(4)-8.51%
Max EPS beat(4)51.46%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)83.33%
EPS NY rev (1m)-1.18%
EPS NY rev (3m)-12.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.58
P/tB 2.65
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS2.16
TBVpS2.11
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.71%
ROE -18.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-96.06%
ROA(5y)-71.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30360.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 31.45
Quick Ratio 31.45
Altman-Z 12.01
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-103.57%
EPS Next 2Y7.74%
EPS Next 3Y-12.62%
EPS Next 5Y25.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-149.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-90.38%
EBIT Next 3Y2.7%
EBIT Next 5Y60.2%
FCF growth 1Y-72.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.04%
OCF growth 3YN/A
OCF growth 5YN/A

NIOCORP DEVELOPMENTS LTD / NB Fundamental Analysis FAQ

What is the fundamental rating for NB stock?

ChartMill assigns a fundamental rating of 3 / 10 to NB.


What is the valuation status for NB stock?

ChartMill assigns a valuation rating of 0 / 10 to NIOCORP DEVELOPMENTS LTD (NB). This can be considered as Overvalued.


Can you provide the profitability details for NIOCORP DEVELOPMENTS LTD?

NIOCORP DEVELOPMENTS LTD (NB) has a profitability rating of 0 / 10.


Can you provide the financial health for NB stock?

The financial health rating of NIOCORP DEVELOPMENTS LTD (NB) is 8 / 10.


Can you provide the expected EPS growth for NB stock?

The Earnings per Share (EPS) of NIOCORP DEVELOPMENTS LTD (NB) is expected to decline by -103.57% in the next year.